Kovack Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,692
Closed -$265K 785
2021
Q4
$265K Buy
3,692
+657
+22% +$50K 0.03% 567
2021
Q3
$217K Buy
3,035
+314
+12% +$24.8K 0.02% 636
2021
Q2
$221K Buy
2,721
+72
+3% +$5.79K 0.03% 609
2021
Q1
$200K Buy
+2,649
New +$193K 0.03% 586

Other funds holding NGVT

Kovack Advisors's NGVT Position: Q1 2022 in Review

Kovack Advisors sold out of Ingevity (NGVT) in Q1 2022, closing a stake of 3,692 shares — an estimated $265K sold.

Kovack Advisors first reported a position in NGVT in Q1 2021 and held it in 4 quarters. The position peaked at $265K in Q4 2021. 274 funds tracked by Wall St. Rank hold NGVT as of Q1 2022.

  • Kovack Advisors reported no remaining Ingevity position as of Q1 2022 after selling out during the quarter.
  • Kovack Advisors sold 3,692 Ingevity shares in Q1 2022, an estimated $265K.
  • Kovack Advisors first reported a position in Ingevity in Q1 2021 and held it in 4 quarters.
  • Kovack Advisors's Ingevity position peaked at $265K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Ingevity as of Q1 2022.

Based on Kovack Advisors's 13F filing for Q1 2022, filed 16 May 2022.